ES2108656B1 - Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico. - Google Patents

Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico.

Info

Publication number
ES2108656B1
ES2108656B1 ES09601181A ES9601181A ES2108656B1 ES 2108656 B1 ES2108656 B1 ES 2108656B1 ES 09601181 A ES09601181 A ES 09601181A ES 9601181 A ES9601181 A ES 9601181A ES 2108656 B1 ES2108656 B1 ES 2108656B1
Authority
ES
Spain
Prior art keywords
phase
origin
extract
obtaining
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09601181A
Other languages
English (en)
Other versions
ES2108656A1 (es
Inventor
Juan Tomas Girbes
Lopez Pilar Jimenez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES09601181A priority Critical patent/ES2108656B1/es
Priority to ES09700401A priority patent/ES2118052B1/es
Priority to EP97924028A priority patent/EP0846467A1/en
Priority to PCT/ES1997/000137 priority patent/WO1997045134A1/es
Publication of ES2108656A1 publication Critical patent/ES2108656A1/es
Application granted granted Critical
Publication of ES2108656B1 publication Critical patent/ES2108656B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN EXTRACTO COMO BASE PARA LA OBTENCION DE MEDICAMENTOS PARA EL TRATAMIENTO DE DOLENCIAS HUMANAS DE ORIGEN VIRICO, DEL TIPO DE LOS PREPARADOS, JARABES, COMPRIMIDOS, TABLETAS, POLVO, CARAMELOS Y SIMILARES, UTILIZADOS COMO MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES HUMANAS DE ORIGEN VIROL, QUE SE COMPONE DE UNA FASE DE OBTENCION DE MEZCLA HOMOGENEA DE FRUTOS DE SAUCO, CORTEZA DE RAMAS DE SAUCO Y HOJAS DE SAUCO, UNA FASE DE TROCEADO DEL MATERIAL LE¥OSO DE DICHA MEZCLA, UNA FASE DE ADICION DE DICHA MEZCLA A AGUA EN EBULLICION, UNA FASE DE DECOCCION DE LA MEZCLA, UNA FASE DE ELIMINACION DE SOLIDOS DEL COMPUESTO ASI OBTENIDO, ASI COMO LOS MEDICAMENTOS OBTENIDOS A PARTIR DE DICHO EXTRACTO.
ES09601181A 1996-05-29 1996-05-29 Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico. Expired - Fee Related ES2108656B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09601181A ES2108656B1 (es) 1996-05-29 1996-05-29 Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico.
ES09700401A ES2118052B1 (es) 1996-05-29 1997-02-25 Perfeccionamientos introducidos a la patente n- 9601181 por procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencia humanas de origen virico.
EP97924028A EP0846467A1 (en) 1996-05-29 1997-05-29 Process for the preparation of an extract used as a base material to obtain medicaments useful for the treatment of human ailment of viral origin
PCT/ES1997/000137 WO1997045134A1 (es) 1996-05-29 1997-05-29 Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601181A ES2108656B1 (es) 1996-05-29 1996-05-29 Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico.

Publications (2)

Publication Number Publication Date
ES2108656A1 ES2108656A1 (es) 1997-12-16
ES2108656B1 true ES2108656B1 (es) 1998-10-01

Family

ID=8294961

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09601181A Expired - Fee Related ES2108656B1 (es) 1996-05-29 1996-05-29 Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico.
ES09700401A Expired - Fee Related ES2118052B1 (es) 1996-05-29 1997-02-25 Perfeccionamientos introducidos a la patente n- 9601181 por procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencia humanas de origen virico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES09700401A Expired - Fee Related ES2118052B1 (es) 1996-05-29 1997-02-25 Perfeccionamientos introducidos a la patente n- 9601181 por procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencia humanas de origen virico.

Country Status (1)

Country Link
ES (2) ES2108656B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB400302A (en) * 1932-05-04 1933-10-26 Frederick Charles Tidbury Improvements relating to herbal preparations, more particularly applicable as an external remedy for rheumatic ailments and arthritis
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物

Also Published As

Publication number Publication date
ES2118052A1 (es) 1998-09-01
ES2118052B1 (es) 1999-03-01
ES2108656A1 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
Thawkar Phytochemical and pharmacological review of Mentha arvensis
Kim et al. Antioxidative activity of resveratrol and its derivatives isolated from seeds of Paeonia lactiflora
Wang et al. A phytochemical, pharmacological and clinical profile of Paederia foetida and P. scandens
Joshi et al. Therapeutic efficiency of Centella asiatica (L.) Urb. An underutilized green leafy vegetable: an overview
CA2235565C (en) Process for the preparation of rhus verniciflua extract and anti-cancer composition containing same
Joshi Bioactive usual and unusual triterpenoids derived from natural sources used in traditional medicine
Sundur et al. A review article of pharmacological activities and biological importance of Calophyllum inophyllum
Phrutivorapongkul et al. Appraisal of biological activities and identification of phenolic compound of African marigold (Tagetes erecta) flower extract
Khatun et al. Medicinal and versatile uses of an amazing, obtainable and valuable grass: Cynodon dactylon
Miraj et al. Study of pharmacological effect of Verbena officinalis Linn: A review
Ngouela et al. Extractives from Bignoniaceae: constituents of the stem bark of Spathodea campanulata
Mukhopadhyay et al. Antiarthritic medicinal plants: A review
Ene-OjoAtawodi et al. Comparative in vitro antioxidant potential of different parts of Ipomoea asarifolia, Roemer & Schultes, Guiera senegalensis, JF Gmel and Anisopus mannii NE Brown
Mwaniki Analysis of blue chamomile essential oil produced by multi-solvent solvent extraction clevenger distillation method
ES2108656B1 (es) Procedimiento para la preparacion de un extracto como base para la obtencion de medicamentos para el tratamiento de dolencias humanas de origen virico.
Biradar et al. Phytochemical screening and immunomodulatory activities of methanolic extract of eclipta alba and centella asiatica
Moke et al. Phytopharmacological Activities of Spondias mombinLinn: A Review: http://www. doi. org/10.26538/tjpps/v3i1. 1
Dhongade et al. Therapeutic potentials of Murraya koenigii Spreng (Rutaceae)
Amit et al. www. ijrap. net
Siddiqui et al. Pharmacological activities of Kahruba (Vateria indica Linn.)-A literary review
Angajala et al. Phytochemical Screening and Pharmacological Examination of Persia Americana Mill (Avocado) Crude Seed Extracts
Rajkumara et al. Isolation of Chemical Constituents from Mimusops elengi bark and Evaluation of Anti-inflammatory activity
Okokon et al. Antidiabetic and hypolipidaemic effects of Hippocratea africana (Hippocrateaceae) in streptozotocin-induced diabetic rats
Pirdhankar et al. Cardioprotective Herbal Plants: A Review
de Sousa et al. Essential Oils: Chemistry and Pharmacological Activities—Part II. Biomedicines. 2024, 12, 1185

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050530